Search

Your search keyword '"Geissler, Edward K."' showing total 258 results

Search Constraints

Start Over You searched for: Author "Geissler, Edward K." Remove constraint Author: "Geissler, Edward K." Database Unpaywall Remove constraint Database: Unpaywall
258 results on '"Geissler, Edward K."'

Search Results

1. Soluble CD46 as a diagnostic marker of hepatic steatosis

4. The effector program of human CD8 T cells supports tissue remodeling

6. Immune profile of patients with peritoneal carcinomatosis selected for CRS-HIPEC therapy

7. Contributors

9. Data from Dietary Immunosuppressants Do Not Enhance UV-Induced Skin Carcinogenesis, and Reveal Discordance between p53-Mutant Early Clones and Carcinomas

10. Supplementary Table 1, Figures 1 - 4 from Dietary Immunosuppressants Do Not Enhance UV-Induced Skin Carcinogenesis, and Reveal Discordance between p53-Mutant Early Clones and Carcinomas

11. Supplementary Table 1, Figures 1 - 4 from Dietary Immunosuppressants Do Not Enhance UV-Induced Skin Carcinogenesis, and Reveal Discordance between p53-Mutant Early Clones and Carcinomas

15. Supplementary Figure 1 from Extracellular Citrate Affects Critical Elements of Cancer Cell Metabolism and Supports Cancer Development In Vivo

16. Data from Extracellular Citrate Affects Critical Elements of Cancer Cell Metabolism and Supports Cancer Development In Vivo

17. Supplementary Figure S6 from Extracellular Citrate Affects Critical Elements of Cancer Cell Metabolism and Supports Cancer Development In Vivo

18. Supplementary Figure S3 from Extracellular Citrate Affects Critical Elements of Cancer Cell Metabolism and Supports Cancer Development In Vivo

19. Supplementary Table S1 from Extracellular Citrate Affects Critical Elements of Cancer Cell Metabolism and Supports Cancer Development In Vivo

20. Supplementary Fig. S1 from Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes

21. Supplementary Figure S6 from Extracellular Citrate Affects Critical Elements of Cancer Cell Metabolism and Supports Cancer Development In Vivo

22. Supplementary Fig. S2 from Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes

23. Supplementary Figure S5 from Extracellular Citrate Affects Critical Elements of Cancer Cell Metabolism and Supports Cancer Development In Vivo

24. Supplementary Figure S2 from Extracellular Citrate Affects Critical Elements of Cancer Cell Metabolism and Supports Cancer Development In Vivo

25. Supplementary Fig. S3 from Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes

26. Supplementary Fig. S2 from Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes

27. Supplementary Fig. S3 from Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes

28. Supplementary Figure S4 from Extracellular Citrate Affects Critical Elements of Cancer Cell Metabolism and Supports Cancer Development In Vivo

29. Supplementary Figure S7 from Extracellular Citrate Affects Critical Elements of Cancer Cell Metabolism and Supports Cancer Development In Vivo

30. Data from Extracellular Citrate Affects Critical Elements of Cancer Cell Metabolism and Supports Cancer Development In Vivo

31. Supplementary Fig. S1 from Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes

32. A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients

34. Early γGT and bilirubin levels as biomarkers for regeneration and outcomes in damaged bile ducts after liver transplantation

35. External validation of biomarkers for immune-related adverse events after immune checkpoint inhibition

37. A non-canonical vitamin K cycle is a potent ferroptosis suppressor

39. EnGraft: a multicentre, open-label, randomised, two-arm, superiority study protocol to assess bioavailability and practicability of Envarsus® versus AdvagrafTM in liver transplant recipients

40. Potential Involvement of Extracellular Citrate in Brain Tumor Progression

45. Development of a Flow Cytometry Assay to Predict Immune Checkpoint Blockade-Related Complications

46. Ribavirin Improves NK Cell IFNγ Response During Sofosbuvir-based DAA Therapy in HCV-infected Liver Transplant Recipients

48. Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients

50. Cancer-associated cells release citrate to support tumour metastatic progression

Catalog

Books, media, physical & digital resources